proteinuria/cáncer

El enlace se guarda en el portapapeles.

Elija el tipo de clasificación

Página 1 desde 1377 resultados

Proteinuria predicts 10-year cancer-related mortality in patients with type 2 diabetes.

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND We conducted a cohort study to determine if proteinuria predicts cancer-related mortality in type 2 diabetic subjects. METHODS Between July 1996 and June 2003, we enrolled 646 type 2 diabetic subjects. Participants were followed-up until December 31, 2008. The vital status was ascertained

Predictive factors for the development of proteinuria in cancer patients treated with bevacizumab, ramucirumab, and aflibercept: a single-institution retrospective analysis.

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

The development of proteinuria restricts the dose of anti-angiogenic agents, thereby reducing their efficacy. Thus, this retrospective study was undertaken to identify predictive factors of the development of angiogenesis inhibitor-induced proteinuria, and to elucidate if there is a difference in

[Proteinuria in Patients with Gastric Cancer Treated with Ramucirumab].

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

Ramucirumab, an antiangiogenic agent, often causes proteinuria as a characteristic adverse effect. We retro- spectively evaluated proteinuria and clarified the significance of the protein/creatinine ratio by using single urine samples from patients with advanced gastric cancer who were

Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignancies.

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND Urinary podocyte excretion (podocyturia) may function as a more specific marker of ongoing glomerular damage. This study sought to analyze the relationship between proteinuria and podocyturia in cancer patients treated with antivascular endothelial growth factor (anti-VEGF)

Rapamycin at six years can exhibit normal renal function without proteinuria or neoplasia after renal transplantation. A single-center experience.

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

Currently, long-term experience with Rapamune (RAPA) after renal transplantation is scarce. We present our experience with RAPA in patients who were included in clinical trials. Between 1996 and 1999, 27 renal transplant patients received RAPA alone or in combination with cyclosporine (CyA). We

Prevalence and prognostic significance of proteinuria in patients with lung cancer.

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

The purpose of the present study was to ascertain the prevalence and prognostic significance of proteinuria in patients with lung cancer. Results of urinary dipstick testing were retrospectively reviewed in 1026 consecutive out-patients with histologically proven primary lung cancer and 475

Proteinuria as a risk factor for mortality in patients with colorectal cancer.

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

OBJECTIVE We investigated the effects of proteinuria and renal insufficiency on all-cause mortality in patients with colorectal cancer, with special emphasis on cancer staging and cancer-related deaths. METHODS We retrospectively studied a cohort of patients with colorectal cancer. In protocol 1,

Incidence and risk of proteinuria with aflibercept in cancer patients: a meta-analysis.

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND Aflibercept is a human recombinant fusion protein with antiangiogenic effects that functions as a decoy receptor to bind vascular endothelial growth factor A. Proteinuria is one of its major adverse effects with a substantial variation in the incidence rate, and the overall risk of

[Renovascular safety of bevacizumab in breast cancer patients. The prognostic value of hypertension and proteinuria].

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND The potential prognostic value of hypertension and proteinuria of anti-vascular endothelial growth factor (VEGF) drugs has not been assessed in routine clinical practice so far in breast cancer. The objectives of the MARS study were to assess the prevalence of proteinuria and hypertension

Lack of association of proteinuria and clinical outcome in patients treated with bevacizumab for metastatic colorectal cancer.

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND Although bevacizumab-related hypertension has been reported as a predictive marker of therapy efficacy, an association between proteinuria and efficacy has not been reported. METHODS Eighty-two consecutive patients with metastatic colorectal cancer treated with bevacizumab as first-line

[Incidence of Proteinuria among Japanese Colorectal Cancer Patients after Receiving Ramucirumab-Cohort Study Using Claim Database]

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

We evaluated the incidence of proteinuria after receiving ramucirumab for the patients with advanced colorectal cancer using claim database. Among 1,706 evaluable patients, incidence proportion of proteinuria was 21.8% and incidence rate (/100 person-years)was 75.3. In patients with history of

[Incidence of proteinuria and nephrotic syndrome in renal vein occlusion caused by a tumor].

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

A retrospective study was conducted in 13 patients with phlebographically diagnosed tumor-induced renal vein occlusion to evaluate the incidence and extent of proteinuria and/or nephrotic syndrome. In 5 patients minimal proteinuria was found, but in none of the patients were the criteria of

Clinical study of bladder cancer: Proteinuria as a predictor of recurrence and efficacy of intravesical bacille Calmette-Guerin therapy.

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

OBJECTIVE We studied the clinical characteristics of bladder cancer, with special attention to the clinical and pathological variables that affect tumor stage, relapse and efficacy of intravesical therapy. METHODS We reviewed the medical records of 152 patients of the Saiseikai Central Hospital who

[Proteinuria and beta 2-microglobulinuria in patients with tumors of the renal pelvis and ureter and in healthy persons from areas of endemic nephropathy].

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

Total proteinuria (SSA test) and beta-2-microglobulinuria (radial immunodiffusion and radioimmunoassay tests) were measured in 60 rural patients with histologically proven tumors of the renal pelvis and ureters and as many individually matched controls. The controls were the first neighbours of the

Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer.

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND The observed association between pioglitazone and bladder cancer could be causal or because of bias in the design of prior studies. We hypothesize that proteinuria testing may lead to detection bias if routine test results for proteinuria lead to a full urinalysis. METHODS We reanalyzed

Únete a nuestra
página de facebook

Herbal & Natural Medicine

La base de datos de hierbas medicinales más completa respaldada por la ciencia

Funciona en 55 idiomas
Curas a base de hierbas respaldadas por la ciencia
Reconocimiento de hierbas por imagen
Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
Leer publicaciones científicas relacionadas con su búsqueda
Buscar hierbas medicinales por sus efectos.
Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.